MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 165 filers reported holding MERIDIAN BIOSCIENCE INC in Q3 2013. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $268,000 | -20.5% | 16,260 | -14.7% | 0.00% | -20.0% |
Q3 2014 | $337,000 | -18.2% | 19,055 | -4.5% | 0.01% | -16.7% |
Q2 2014 | $412,000 | -9.5% | 19,952 | -4.5% | 0.01% | -14.3% |
Q1 2014 | $455,000 | +24.0% | 20,901 | +51.2% | 0.01% | +16.7% |
Q4 2013 | $367,000 | +4487.5% | 13,820 | +3595.2% | 0.01% | – |
Q2 2013 | $8,000 | – | 374 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |